← Back to Search

18-F-Flortaucipir for Alzheimer's Disease

Phase 4

Waitlist Available

Led By Michelle Mielke, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

Study Summary

This trial will investigate if ovarian hormones are linked to Alzheimer's disease in women.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

18F-Flortaucipir PET imaging

Pittsburgh compound-B PET imaging

Trial Design

1Treatment groups

Experimental Treatment

Group I: WomenExperimental Treatment1 Intervention

18F-Flortaucipir and 11C-Pittsburgh compound-B radioligands will be used for experimental PET imaging of beta-amyloid and neurofibrillary tau pathology

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,685 Total Patients Enrolled

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,088 Total Patients Enrolled

Michelle Mielke, PhDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA sanctioned 18-F-Flortaucipir for use in medical practice?

"Our team has rated the safety of 18-F-Flortaucipir a 3, as it is currently in its fourth stage of clinical trials and has already been approved for use."

Answered by AI

Is enrollment still open for participants in this clinical trial?

"Clinicaltrials.gov reveals that this medical experiment is no longer accepting participants, as the last update was on October 14th 2021. Despite this, there are presently 546 other studies actively recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

Michelle M. Mielke, PhD 2019. "Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03821857.